Yogesh S. Sanghvi, PhD

In 1981, Dr. Sanghvi received his Ph.D. in organic chemistry from National Chemical Laboratory (Pune, India), where he worked on the synthesis of natural products. From 1982 – 1985, his post-doctoral research on the synthesis of modified nucleosides was carried out at the University of London with Professor C.B. Reese. In 1986, he joined the Nucleic Acids Research Institute at ICN Pharmaceuticals, California. At ICN, he was involved in the design, synthesis and screening of novel nucleosides and nucleotides as antiviral and antitumor agents. From 1989 – 2003, he worked at Ionis Pharmaceuticals, California. The focus of his research at Ionis has been on the discovery, development and manufacture of oligonucleotide-based therapeutics, DNA and RNA modifications in combinatorial and diagnostic research. Dr. Sanghvi has authored/co-authored over 210 scientific publications in leading journals, including several book chapters and has co-inventorship of more than 40 patents. Throughout his pr